Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bimiralisib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bimiralisib Demonstrates 92% Clearance Rate In Actinic Keratosis
    Bimiralisib Demonstrates 92% Clearance Rate In Actinic Keratosis

    06 Oct 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-10-06/bimiralisib-topical-pi3kmtor-inhibitor-shows-up-to-92-clearance-rate-and-superior-tolerability-in

    PHARMAWEB
    06 Oct 2025
    Share Share